| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 778,193 | 721,859 | 600,294 | 799,199 | | Cost of Revenue | 623,713 | 576,025 | 522,687 | 650,009 | | | Gross Profit | 154,480 | 145,834 | 77,607 | 149,190 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 79,274 | 80,804 | 81,436 | 88,620 | | Non Recurring | 3,157 | (654) | (2,503) | 244,999 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 82,702 | 65,684 | (1,326) | (184,429) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 13,843 | 3,582 | (280) | (821) | | Earnings Before Interest And Taxes | 85,892 | 69,266 | (1,606) | (185,250) | | Interest Expense | 43,951 | 44,073 | 43,919 | 46,583 | | Income Before Tax | 41,941 | 25,193 | (45,525) | (231,833) | | Income Tax Expense | (5,983) | 9,632 | (13,270) | (14,641) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 47,924 | 15,561 | (32,255) | (217,192) | | | Non-recurring Events | | Discontinued Operations | (6,125) | 6,650 | (525) | (661) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 54,232 | 22,211 | (32,780) | (217,853) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $54,232 | $22,211 | ($32,780) | ($217,853) |
|
0.01% Nasdaq 
Income Statement
